Angiomax in Patients With HIT/HITTS Type II Undergoing CPB

Summary

The purpose of this study is to demonstrate that in patients with heparin-induced thrombocytopenia (HIT)/heparin-induced thrombocytopenia and thrombosis syndrome (HITTS) Type II undergoing cardiac surgery on cardiopulmonary bypass (CPB), Angiomax is a safe and effective anticoagulant.

Timeline

Start

2004-04

Primary completion

2005-10

Completion

—

Drugs

Indications